Stockreport

OpGen Completes Clinical Trials for its Initial FDA 510(k) Submission

OpGen, Inc.  (OPGN) 
Last opgen, inc. earnings: 11/6 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.opgen.com
PDF GAITHERSBURG, Md., Feb. 05, 2019 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN) announced today that it has completed the clinical trials needed to support its 510(k) [Read more]